ArticleDiabetes technology & therapeutics2009
New and improved methods to characterize glycemic variability using continuous glucose monitoring.
Article in Diabetes technology & therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01524705 (FLAT-SUGAR), which is not on this map. Cited by 105 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR
Who cites it
105 citing papers in PubMed.
- Dietary Modification with Food Order and Divided Carbohydrate Intake Improves Glycemic Excursions in Healthy Young Women.Nutrients · 2025Trial
- Glucoregulatory status modulates acute cognitive effects of repeated low-glycaemic snack consumption in older adults: a decentralized randomized controlled trial.European journal of nutrition · 2025Trial
- Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial.BioMed research international · 2021Trial
- Assessment of Glucose Control Metrics by Discriminant Ratio.Diabetes technology & therapeutics · 2020Trial
- Extremely short duration interval exercise improves 24-h glycaemia in men with type 2 diabetes.European journal of applied physiology · 2018Trial
- Trial
- Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.Scientific reports · 2018Trial
- Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy.Scientific reports · 2018Trial
- Effect of Oral Pre-Meal Administration of Betaglucans on Glycaemic Control and Variability in Subjects with Type 1 Diabetes.Nutrients · 2017Trial
- Hyperinsulinemic normoglycemia decreases glucose variability during cardiac surgery.Journal of anesthesia · 2017Trial
- Substituting whole grains for refined grains in a 6-wk randomized trial favorably affects energy-balance metrics in healthy men and postmenopausal women.The American journal of clinical nutrition · 2017Trial
- Trial
- Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.Diabetes technology & therapeutics · 2015Trial
- Clinical impact of sample interference on intensive insulin therapy in severely burned patients: a pilot study.Journal of burn care & research : official publication of the American Burn AssociationTrial
- Transition from CSII to second-generation basal insulin analogues in hospitalized T2DM patients: a CGM-based study.BMC endocrine disorders · 2026Article
- Article
- The Impact of Glycaemic Variability on Vascular Dysfunction in Diabetes.Biomolecules · 2025Review
- Glucodensity functional profiles outperform traditional continuous glucose monitoring metrics.Scientific reports · 2025Article
- Multidimensional Sleep Health, Glycemic Control, and Self-reported Outcomes in Type 1 Diabetes: A Cross-sectional Study.The Journal of clinical endocrinology and metabolism · 2025Article
- Effects of L-Arabinose on Glycemic Responses After the Consumption of Sucrose-Rich Foods in Individuals with Impaired Fasting Glucose: A Randomized Controlled Cross-Over Trial.The Journal of nutrition · 2025Article
45 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlycemic variability is a possible risk factor for development of complications from diabetes. Numerous methods have been used to characterize glycemic variability.
methodsWe propose several new methods to characterize glycemic variability. We evaluated these methods empirically and theoretically and compared them with previous methods.
resultsWe describe (1) extension and generalization of the mean amplitude of glycemic excursion (MAGE), i.e., "within day variability," (2) extension and generalization of the mean of daily differences (MODD), i.e., the "between day-within time points variability," (3) "between daily means variability," (4) "between time points variability" of the glucose profile averaged over several days, (5) "within series variability" for a time segment of any arbitrary length, (6) new measures of the stability of the daily glycemic patterns, (7) new types of graphical displays, including within day variability, between day-within time points variability, and between daily means variability versus total variability, and between daily means variability versus within day variability, and (8) new methods to evaluate whether within series and between day-within time points variability fluctuate systematically by time of day. We examined the new measures in relation to previous measures of glycemic variability using correlation analysis on a clinical dataset for 85 subjects. MAGE, MODD, and continuous overall net glycemic action (CONGA(n)) are directly proportional to total standard deviation (SD). MAGE is highly correlated with both total SD and within day variability but weakly correlated with measures of between day variability. MODD is highly correlated with between day-within time points variability and total SD but weakly correlated with measures of within day variability.
conclusionsWe provide a systematic, logical framework to characterize multiple aspects of glycemic variability and have implemented a simple, practical computing format. This approach can help clinical researchers and clinicians identify the major sources of variability for any given patient and monitor responses to interventions.
Indexed as
Identifiers
19764834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.